|
CEBPZ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.62890043067898E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.52059525765958E-11 |
| Normal-vs-Stage2 |
1.798490E-03 |
| Normal-vs-Stage3 |
1.164440E-02 |
| Normal-vs-Stage4 |
3.139800E-01 |
| Stage1-vs-Stage2 |
6.061000E-01 |
| Stage1-vs-Stage3 |
7.494300E-02 |
| Stage1-vs-Stage4 |
7.773700E-02 |
| Stage2-vs-Stage3 |
4.149000E-01 |
| Stage2-vs-Stage4 |
2.829400E-01 |
| Stage3-vs-Stage4 |
6.278000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.1746053542654E-11 |
| Normal-vs-AfricanAmerican |
4.492300000003E-05 |
| Normal-vs-Asian |
2.248600E-01 |
| Caucasian-vs-AfricanAmerican |
1.900830E-01 |
| Caucasian-vs-Asian |
5.273000E-01 |
| AfricanAmerican-vs-Asian |
8.756800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.08606523353228E-13 |
| Normal-vs-Female |
2.235900E-02 |
| Male-vs-Female |
5.26290000024687E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.99720000000547E-05 |
| Normal-vs-Extreme_Weight |
1.36679556561603E-12 |
| Normal-vs-Obese |
2.759700E-04 |
| Normal-vs-Extreme_Obese |
1.138340E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.188200E-01 |
| Normal_Weight-vs-Obese |
4.277400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.429400E-01 |
| Extreme_Weight-vs-Obese |
1.021890E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.879000E-01 |
| Obese-vs-Extreme_Obese |
4.310000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.959000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.5765000005441E-07 |
| Normal-vs-Age(61-80Yrs) |
5.95601346020658E-12 |
| Normal-vs-Age(81-100Yrs) |
5.608400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.792030E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.593500E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.471740E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.751770E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.163630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.062200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.00169872396805E-11 |
| Normal-VS-Type2 PRCC |
7.83279999749809E-08 |
| Normal-VS-KIRP CIMP |
3.675000E-01 |
| Normal-VS-Unclassified PRCC |
3.976800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.298600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.095990E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.813600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.397300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.484000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.476900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78870029898803E-10 |
| Normal-vs-N1 |
8.848000E-01 |
| Normal-vs-N2 |
4.660100E-03 |
| N0-vs-N1 |
1.159310E-03 |
| N0-vs-N2 |
5.629200E-01 |
| N1-vs-N2 |
2.491800E-01 |
|
|
